8-KEarnings & ResultsExhibits & Filings

ELI LILLY & Co 8-K Report, Financial Results (Dec 15, 2020)

Filed December 15, 2020For Securities:LLY

Summary

Eli Lilly and Company (LLY) filed an 8-K on December 15, 2020, to update its financial guidance for both 2020 and 2021. This report indicates a significant event where the company provided forward-looking financial projections to the investment community. The filing emphasizes the use of non-GAAP financial measures, which exclude items such as amortization of intangibles and other variable or difficult-to-predict costs. Lilly believes these non-GAAP measures offer a clearer view of operational trends and performance by removing potentially distorting factors, aiding investors in making meaningful period-over-period comparisons.

Key Highlights

  • 1Eli Lilly updated its financial guidance for both fiscal year 2020 and issued guidance for fiscal year 2021.
  • 2The company held a teleconference for analysts and media to discuss the updated financial outlook.
  • 3The press release, included as an exhibit, contains the detailed financial guidance.
  • 4LLY utilizes non-GAAP financial measures, excluding items like amortization of intangibles and other variable costs, to present performance.
  • 5The company believes these non-GAAP measures enhance comparability and provide insights into underlying operating trends.
  • 6Investors are advised to consider these non-GAAP measures alongside, not as a substitute for, GAAP financial results.

Frequently Asked Questions